AzTrials
AzTrials

Post Operative PainNCT05863624

Open and Endoscopic Technique in Female Inguinal Hernia Repair. FemaleHernia

A study testing Open hernioplasty and TEP hernioplasty in people with Post Operative Pain, run by Kuopio University Hospital at 1 site in Finland.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized study compares open inguinal hernia repair (Lichtenstein hernioplasty) to endoscopic repair (TEP) in terms of chronic pain and recurrences in one and five years after operation. Read more about this study

Who is it for?
Ages 18 to 80 years, women only
Conditions the study is for
Post Operative Pain
What is being tested?
Open hernioplasty and TEP hernioplasty
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
170 participants
Where
1 siteFinland
Study dates
1 Sep 2024to 31 Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • primary inguinal hernia in females

Who cannot join

  • emergency operation
  • recurrent hernia
  • groin pain without hernia
  • frail and sick patient ASA ≥ 4

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hannu EK Paajanen, MD contact

0405263101 ext. +358

paajanen@surffi.fi

Finland1 site
  • Mikkeli Central Hospital

    Mikkeli, 50100

Other trials in Finland

About this study

Official title: Postoperative Pain and Recurrences After Totally Extraperitoneal Endoscopic (TEP) vs. Lichtenstein Hernioplasty in Female Inguinal Hernia Repair: a Prospective Randomized Multi-center Study

This randomized study compares open inguinal hernia repair (Lichtenstein hernioplasty) to endoscopic repair (TEP) in terms of chronic pain and recurrences in one and five years after operation.

Read the detailed description

The best operative technique in female inguinal hernia is not known. Some register studies recommend always laparoscopic hernia repair in females, but there are no randomized studies to show that laparoscopic repair is better than open hernioplasty. Our study compares operative complications, chronic pain and recurrences in Lichtenstein operation to totally endoscopic hernia repair (TEP) in 170 female patients with primary inguinal hernia. The patients are operated in six Finnish hospitals, randomized into 85 Lichtenstein vs 85 TEP and followed 1 week, 4 weeks, 12 months and 5 years. Main end-point in postoperative pain after one year, sencondary endpoints are sick leave, return to normal physical activity, complications of treatment, re-operations, chronic pain and costs of treatment.

Being tested
Open hernioplasty, TEP hernioplasty
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Open hernioplastyProcedure or surgery

    Also called Open Lichtenstein hernia repair

    Inguinal hernia is operated using open surgery

  • TEP hernioplastyProcedure or surgery

    Also called totally endoscopic hernia repair (TEP)

    Inguinal hernia is operated using laparoendoscopic technique

Study groups in NCT05863624
Study groupRoleWhat they receive
Open hernioplastyExperimentalOpen Lichtenstein hernia repair
Receives: Procedure: Open hernioplasty
TEP hernioplastyActive comparatortotally endoscopic hernia repair (TEP)
Receives: Procedure: TEP hernioplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Chronic pain

    Postoperative inguinal pain (vas scores 0-10) after 1 week, 4 weeks and one year of surgery

    Measured: from 1 week to one year

Secondary outcomes (4)
  1. Complications

    Postoperative complications of surgery (wound infection, hemorrhage)

    Measured: 1 month

  2. Recurrence

    Hernia recurrences after 5 years

    Measured: 5 years

  3. Sick leave

    how many days the patient is not working after surgery

    Measured: 0-30 days

  4. Treatment costs

    how much in euros the surgical treatment will cost

    Measured: 0-30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2023
  2. Study start1 Sep 2024 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized follow-up study
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
170 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05863624
Sponsor's protocol ID
KUH5200667
Status last verified
May 2023
First submitted
17 Apr 2023
Last updated
6 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Open hernioplasty and TEP hernioplasty in people with Post Operative Pain, run by Kuopio University Hospital at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hannu EK Paajanen, MD (0405263101 ext. +358, paajanen@surffi.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Chronic pain (time frame: from 1 week to one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in